Manufacturing hurdles slowing Covid jabs rollout
Industry players say a major challenge was a global shortage of more than 100 components and ingredients needed for vaccine manufacturing.
Nina Larson - Removing intellectual property protections from Covid-19 vaccines or pressuring companies into technology sharing will not speed up production of the jabs, and could
...
If you are an active subscriber and the article is not showing, please log out and back in. Free access to articles from 12:00.
Comments
Namibian Sun
No comments have been left on this article